Catalyst
Slingshot members are tracking this event:
Phase 2 open-label trial data of FG-3019 for Pancreatic cancer to be presented at 2016 Gastrointestinal Cancers Symposium of ASCO GI in January 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FGEN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 22, 2016
Occurred Source:
http://abstracts.asco.org/173/AbstView_173_160293.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fg-3019, Pancreatic Cancer, Gastrointestinal Cancers Symposium
